234 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 10:27
197 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:58
210 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:28
226 0 Fei Yifei 2016-8-22 publish Last reply on 2016-8-22 09:23
298 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 12:03
230 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:41
255 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:14
245 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 10:42
315 0 Fei Yifei 2016-8-20 publish Last reply on 2016-8-20 21:47
235 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 20:23
283 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 19:57
296 0 Wuhan Medical 2016-8-20 publish Last reply on 2016-8-20 15:40
203 0 special characteristics 2016-8-20 publish Last reply on 2016-8-20 09:32
202 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 16:36
231 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 14:56
238 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 11:52
227 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 10:29
246 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 09:23
284 0 special characteristics 2016-8-19 publish Last reply on 2016-8-19 09:03
221 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 19:22
195 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 17:20
233 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 16:14
260 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 13:00
237 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 11:19
245 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 11:17
Point rules of this version Post Rebroadcast to the audience